Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-1713

MC38-CCR5-Cell-Line

Home » MC38-CCR5-Cell-Line

Background of MC38-CCR5-Cell-Line

CCR5, also known as CD195, is a G protein-linked seven transmembrane domain receptor that belongs to the beta chemokine receptors family, which is a protein on the surface of white blood cells that is involved in the immune system. CCR5 is predominantly expressed on T cells, macrophages, dendritic cells, eosinophils, microglia and a subpopulation of either breast or prostate cancer cells. CCR5 inhibitors blocked the migration and metastasis of breast and prostate cancer cells that expressed CCR5, that may function as a new therapeutic target.

Specifications

Catalog Number:
KC-1713
Cell Line Name:
MC38-CCR5-Cell-Line
Clone Number
Host Cell Line:
Mouse MC38 cell line
Description:
Stable MC38 cell line expressing exogenous human CCR5 gene
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% RPMI1640+20% FBS+10% DMSO
Propagation Medium:
RPMI1640+10%FBS+100µg/mL Hygromycin B
Selection Marker:
HygromycinB
Morphology:
Epithelial
Subculture:
Split saturated culture 1:2-1:5 every 3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 48 hours
Mycoplasma Status:
Negative
In Vivo Validation:
NA

Cell Line Generation

MC38 human CCR5 cell line was generated using a lentiviral vector expressing the human CCR5 sequence.

Characterization

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS + 100µg/mL Hygromycin B)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:2-1:5 every 3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI-1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Aldinucci D, Borghese C, Casagrande N. The CCL5/CCR5 Axis in Cancer Progression. Cancers (Basel). 2020 Jul 2;12(7):1765.
  2. Hemmatazad H, Berger MD. CCR5 is a potential therapeutic target for cancer. Expert Opin Ther Targets. 2021 Apr;25(4):311-327.
  3. Prathipati PK, Mandal S, Destache CJ. A review of CCR5 antibodies against HIV: current and future aspects. Ther Deliv. 2019 Feb;10(2):107-113.